Home » Authors » Trista Morrison

Articles by Trista Morrison

Aspreva Ends Speculation With $915M Acquisition

Oct. 19, 2007

By Trista Morrison

Aspreva Ends Speculation With $915M Acquisition

Oct. 19, 2007

By Trista Morrison

Cubist Gets Option To Acquire Illumigen; Funds HCV Drug

Oct. 18, 2007

By Trista Morrison

Cubist Pharmaceuticals Inc. moved to expand its pipeline beyond Cubicin (daptomycin for injection) by picking up an exclusive option to acquire Illumigen Biosciences Inc. (BioWorld Today)

Cubist Gets Option To Acquire Illumigen; Funds HCV Drug

Oct. 18, 2007

By Trista Morrison

Cubist Pharmaceuticals Inc. moved to expand its pipeline beyond Cubicin (daptomycin for injection) by picking up an exclusive option to acquire Illumigen Biosciences Inc. (BioWorld Today)

Cytokinetics Gets $75M Option; Aastrom Raises $13.5M Publicly

Oct. 17, 2007

By Trista Morrison

Cytokinetics Gets $75M Option; Aastrom Raises $13.5M Publicly

Oct. 17, 2007

By Trista Morrison

Memory Falls As MEM 1003 Misses In Phase IIa AD Trial

Oct. 16, 2007

By Trista Morrison

Memory Falls As MEM 1003 Misses In Phase IIa AD Trial

Oct. 16, 2007

By Trista Morrison

NewCo News: Meditrina Teaches Cancer Fighter New Tricks In Women's Health

Oct. 15, 2007

By Trista Morrison

NewCo News: Meditrina Teaches Cancer Fighter New Tricks In Women's Health

Oct. 15, 2007

By Trista Morrison

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...